128 related articles for article (PubMed ID: 3038583)
1. Marrow donor immunity to herpes simplex virus: association with acute graft-versus-host disease.
Gratama JW; Sinnige LG; Weijers TF; Zwaan FE; van Heugten JG; Stijnen T; D'Amaro J; The TH; Hekker AC; de Gast GC
Exp Hematol; 1987 Aug; 15(7):735-40. PubMed ID: 3038583
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients.
Hägglund H; Boström L; Remberger M; Ljungman P; Nilsson B; Ringdén O
Bone Marrow Transplant; 1995 Dec; 16(6):747-53. PubMed ID: 8750264
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus-host disease.
Gratama JW; Fibbe WE; Naipal AM; Slats J; Stijnen T; D'Amaro J; Bolhuis RL; The TH; Janssen J
Bone Marrow Transplant; 1986 Dec; 1(2):141-6. PubMed ID: 2844332
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant herpes virus serology and chronic graft-versus-host disease.
Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
Bone Marrow Transplant; 1989 Sep; 4(5):547-52. PubMed ID: 2551436
[TBL] [Abstract][Full Text] [Related]
5. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
6. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
7. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
Bone Marrow Transplant; 1998 Oct; 22(8):755-61. PubMed ID: 9827972
[TBL] [Abstract][Full Text] [Related]
10. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors.
Löwenberg B; Wagemaker G; van Bekkum DW; Sizoo W; Sintnicolaas K; Hendriks WD; Hagenbeek A
Bone Marrow Transplant; 1986 Dec; 1(2):133-40. PubMed ID: 3332128
[TBL] [Abstract][Full Text] [Related]
12. A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation.
Boström L; Ringdén O; Gratama JW; Jacobsen N; Prentice HG; Zwaan FE; Nilsson B
Bone Marrow Transplant; 1990 May; 5(5):321-6. PubMed ID: 2190659
[TBL] [Abstract][Full Text] [Related]
13. No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients.
Murata M; Emi N; Hirabayashi N; Hamaguchi M; Goto S; Wakita A; Tanimoto M; Saito H; Kodera Y; Morishita Y;
Int J Hematol; 2000 Oct; 72(3):371-5. PubMed ID: 11185997
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
Atkinson K; Arthur C; Bradstock K; Dale B; Downs K; Gibson J; Golenia M; Ho J; Joshua D; Juttner C
Bone Marrow Transplant; 1995 Sep; 16(3):401-5. PubMed ID: 8535313
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-host disease after marrow transplantation.
Storb R
Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
[TBL] [Abstract][Full Text] [Related]
16. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
17. An analysis of factors predisposing to chronic graft-versus-host disease.
Ringdén O; Paulin T; Lönnqvist B; Nilsson B
Exp Hematol; 1985 Nov; 13(10):1062-7. PubMed ID: 2996920
[TBL] [Abstract][Full Text] [Related]
18. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
Ringdén O; Remberger M; Persson U; Ljungman P; Aldener A; Andström E; Aschan J; Bolme P; Dahllöf G; Dalianis T
Bone Marrow Transplant; 1995 Apr; 15(4):619-25. PubMed ID: 7655390
[TBL] [Abstract][Full Text] [Related]
19. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]